Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

8.00
0.0000
Volume:5.04K
Turnover:40.30K
Market Cap:2.51B
PE:-190.02
High:8.00
Open:8.00
Low:8.00
Close:8.00
Loading ...

Truist Financial Sticks to Its Buy Rating for Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
2 hours ago

BRIEF-Amneal Pharmaceuticals Unit Prices $600 Mln Senior Secured Notes Due 2032 - SEC Filing

Reuters
·
14 hours ago

Amneal Pharmaceuticals Announces $600 Million Private Placement of Senior Secured Notes Due 2032

Reuters
·
16 hours ago

Why Investors Shouldn't Be Surprised By Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Low P/S

Simply Wall St.
·
19 hours ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
21 Jul

Amneal Pharmaceuticals Inc. Announces Private Offering of $750 Million Senior Secured Notes Due 2032

Reuters
·
21 Jul

Amneal Pharmaceuticals Reports 3% Rise in Q2 2025 Net Revenue, Income Before Taxes Up Significantly

Reuters
·
21 Jul

Knight Therapeutics Inc. Announces Health Canada's Acceptance of New Drug Submission for CREXONT® Extended-Release Capsules

Reuters
·
18 Jul

Amneal Pharmaceuticals (AMRX) Gets a Buy from Goldman Sachs

TIPRANKS
·
16 Jul

Press Release: Amneal to Report Second Quarter 2025 Results on August 5, 2025

Dow Jones
·
09 Jul

Amneal Pharmaceuticals Releases 2024 ESG Report Highlighting Business Initiatives

Reuters
·
27 Jun

Amneal Pharmaceuticals Announces Positive Phase 3 Results for Biosimilar to XOLAIR, BLA Filing Expected in Q4 2025

Reuters
·
25 Jun

Director Patel Gautam Reports Disposal of Common Shares of Amneal Pharmaceuticals Inc

Reuters
·
19 Jun

Director Gautam Patel Reports Disposal of Common Shares in Amneal Pharmaceuticals Inc

Reuters
·
13 Jun

Amneal Pharmaceuticals Inc. Receives FDA Approval for Prednisolone Acetate Ophthalmic Suspension; Commercial Launch Set for Q3 2025

Reuters
·
12 Jun

Amneal Pharmaceuticals (AMRX) Receives a Buy from Goldman Sachs

TIPRANKS
·
09 Jun

Amneal Pharmaceuticals initiated with a Buy at Goldman Sachs

TIPRANKS
·
06 Jun

Amneal Pharmaceuticals Inc. Unveils Strategic Growth Plans and Product Pipeline Expansion in New Presentation

Reuters
·
05 Jun

Amneal Recalls Three Lots of Urinary Tract Infection Tablets

MT Newswires Live
·
05 Jun

Executive Vice President Nikita Shah Reports Disposal of Amneal Pharmaceuticals Inc. Common Shares

Reuters
·
20 May